Agios Pharmaceuticals, Inc

(NASDAQ:AGIO)

Latest On Agios Pharmaceuticals, Inc (AGIO):

Date/Time Type Description Signal Details
2023-05-24 13:19 ESTNewsAgios Pharmaceuticals: Good Execution, A Good Deal Of Cash, Some HurdlesN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:00 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37MN/A
2023-05-03 20:46 ESTNewsAgios Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-02-24 01:00 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q4 2022 Earnings Call TranscriptN/A
2023-02-23 11:31 ESTNewsAgios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35MN/A
2023-02-22 09:46 ESTNewsAgios Pharma: Multiple Growth Catalysts If Pyrukynd Conversions Pull ThroughN/A
2023-01-11 19:46 ESTNewsAgios Pharmaceuticals (AGIO) presents at 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2022-12-12 09:07 ESTNewsAgios rare blood disorder drug Pyrukynd sustains benefits in patients in long term dataN/A
2022-11-17 17:06 ESTNewsAgios Pharmaceuticals upgraded to neutral at Goldman Sachs on Pyrukynd outlookN/A
2022-11-12 00:39 ESTNewsAgios granted EU approval for Pyrukynd in pyruvate kinase deficiencyN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-03 22:53 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72MN/A
2022-10-30 23:18 ESTNewsAgios Pharmaceuticals: A Big Year On The HorizonN/A
2022-10-27 21:23 ESTNewsAgios sells its rights to royalties on U.S. sales of cancer drug Tibsovo for $131.8MN/A
2022-09-19 18:38 ESTNewsAgios appoints Cecilia Jones as finance chiefN/A
2022-09-16 22:56 ESTNewsAgios Pyrukynd for rare blood disorder gets EMA panel backing for approval in EUN/A
2022-09-07 13:53 ESTNewsAgios CFO Jonathan Biller to quitN/A
2022-09-01 18:52 ESTNewsAgios adds more than 13% after Novo deal to acquire rival FormaN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:04 ESTNewsAgios stock rises as Q2 sees new drug Pyrukynd bring in revenueN/A
2022-08-04 07:32 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.68 beats by $0.07N/A
2022-07-27 15:35 ESTNewsAgios gains as blood disorder therapy draws positive viewsN/A
2022-07-26 12:48 ESTNewsAgios Pharmaceuticals Is A Buy On Coming Revenue RampN/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals hires new CEON/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals appoints new board chair, CEON/A
2022-06-18 02:50 ESTNewsAgios Pharmaceuticals (AGIO) Presents At EHA 2022 Conference - SlideshowN/A
2022-05-18 02:34 ESTNewsAgios chief scientific officer to depart amid layoffs as company pivots to genetic diseasesN/A
2022-05-10 23:23 ESTNewsAgios: Approved Product, Upcoming CatalystsN/A
2022-05-10 01:38 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.74 beats by $0.07, revenue of $0.83M misses by $1.88MN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:11 ESTNewsAgios Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-02-25 04:07 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-25 04:06 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:21 ESTNewsAgios Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-24 08:20 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.81 misses by $0.12N/A
2022-02-23 12:21 ESTNewsAgios Pharmaceuticals With FDA Approval Is A BuyN/A
2022-02-19 06:37 ESTNewsAgios Pharmaceuticals' mitapivat approved by FDA for pyruvate kinase deficiencyN/A
2022-02-19 06:36 ESTNewsAgios vindicated with FDA approval for Pyrukynd - H.C. WainwrightN/A
2022-02-18 08:40 ESTNewsAgios Pyrukynd for rare blood disorder gets US FDA approvalN/A
2022-01-20 15:39 ESTNewsAgios Before The February PDUFAN/A
2021-12-14 09:40 ESTNewsAgios presents mitapivat long-term data in PK deficiency at ASH 2021N/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Dr. Jackie Fouse on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-03 07:29 ESTNewsAgios Pharmaceuticals EPS beats by $1.46N/A
2021-11-02 11:38 ESTNewsAgios Pharmaceuticals Q3 2021 Earnings PreviewN/A

About Agios Pharmaceuticals, Inc (AGIO):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA (enasidenib), an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has completed Phase II clinical trials to treat IC eligible frontline AML; that is in Phase III clinical trials for treating IC ineligible frontline AML; and that is in Phase III clinical trials for the treatment of cholangiocarcinoma, as well as in early stage clinical development to treat glioma and solid tumors. In addition, the company is developing IDHIFA, which has completed Phase II clinical study for treating IC eligible frontline AML; and that is in Phase I/II clinical trials for the treatment of IC ineligible frontline AML. Further, it is developing mitapivat, which is in Phase III clinical trials to treat pyruvate kinase deficiency, as well as in Phase II clinical study for treating thalassemia and sickle cell disease; vorasidenib (AG-881) that is in Phase I clinical trials for the treatment of solid tumors, including glioma; AG-270, which is in Phase I dose-escalation trial to treat methylthioadenosine phosphorylase deleted tumors; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is based in Cambridge, Massachusetts.

AGIO Quotes by TradingView

See Advanced Chart

General

  • Name Agios Pharmaceuticals, Inc
  • Symbol AGIO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 562
  • Fiscal Year EndDecember
  • IPO Date2013-07-24
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.agios.com
View More

Valuation

  • Forward PE 8.1
  • Price/Sales (Trailing 12 Mt.) 17.51
  • Price/Book (Most Recent Quarter) 8.98
  • Enterprise Value Revenue 15.36
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.07
  • Next Year EPS Estimate -$6.10
  • Next Quarter EPS Estimate -$1.29
  • Profit Margin -161%
  • Operating Margin -156%
  • Return on Assets -23%
  • Return on Equity -63%
  • Revenue 203.2 million
  • Earnings Per Share -$6.67
  • Revenue Per Share $2.95
  • Gross Profit -167079000
  • Quarterly Earnings Growth 24.3%
View More

Highlights

  • Market Capitalization 3.38 billion
  • EBITDA -399112000
  • PE Ratio 1.63
  • Analyst Target Price $64.89
  • Book Value Per Share $5.77
View More

Share Statistics

  • Shares Outstanding 69.36 million
  • Shares Float 61.75 million
  • % Held by Insiders 1133%
  • % Held by Institutions 92.34%
  • Shares Short 5.82 million
  • Shares Short Prior Month 5.68 million
  • Short Ratio 8.4
  • Short % of Float 11%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.62
  • 52 Week High $58.93
  • 52 Week Low $32.47
  • 50 Day Moving Average 50.87
  • 200 Day Moving Average 42.95
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Agios Pharmaceuticals, Inc (AGIO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Agios Pharmaceuticals, Inc (AGIO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$44.05 million-$1.41-$1.31-7.96%
2020-09-302020-11-05$34.71 million-$1.43-$1.36-5.47%
2020-06-302020-07-30$N/A-$1.31-$1.363.72%
2020-03-312020-04-30$N/A-$0.59-$1.6463.94%
2019-12-312020-02-13$35.44 million-$1.60-$1.684.94%
2019-09-302019-10-31$26.02 million-$1.81-$1.81-0.22%
2019-06-302019-08-01$26.22 million-$1.87-$1.70-9.89%
2019-03-312019-05-02$30.23 million-$1.59-$1.759.24%
2018-12-312019-02-14$30.01 million-$1.58-$1.664.62%
2018-09-302018-11-01$15.2 million-$1.63-$1.62-0.73%
2018-06-302018-08-02$40.41 million-$1.19-$1.5523.07%
2018-03-312018-05-04$8.76 million-$1.63-$1.651.41%
2017-12-312018-02-14$9.8 million-$1.81-$1.61-12.63%
2017-09-302017-11-01$11.36 million-$1.59-$1.7810.46%
2017-06-302017-08-08$11.35 million-$1.78-$1.57-13.53%
2017-03-312017-05-04$10.51 million-$1.56-$1.8013.19%
2016-12-312017-02-16$22.65 million-$1.34-$1.5111.38%
2016-09-302016-11-03$8.99 million-$1.63-$1.51-8.2%
2016-06-302016-08-04$6.98 million-$1.47-$1.30-12.77%
2016-03-312016-05-05$31.28 million-$0.61-$0.9334.47%
2015-12-312016-02-18$6.22 million-$1.08-$0.53-102.21%
2015-09-302015-11-05$5.48 million-$1.07-$0.88-21.59%
2015-06-302015-08-06$13.22 million-$0.85-$0.46-84.78%
2015-03-312015-05-07$34.2 million-$0.13-$0.9285.87%
2014-12-312015-02-17$14.64 million-$0.76-$0.58-31.03%
2014-09-302014-11-07$33.9 million$0.10-$0.52119.23%
2014-06-302014-08-07$8.41 million-$0.54-$0.40-35%
2014-03-312014-05-08$8.41 million-$0.39-$0.37-5.41%
2013-12-312014-03-06$6.74 million-$0.40-$0.34-17.65%
2013-09-302013-11-07$6.27 million-$0.47-$0.29-62.07%
2013-06-302013-09-05$6.27 million-$2.80-$0.32-775%

Agios Pharmaceuticals, Inc (AGIO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Agios Pharmaceuticals, Inc (AGIO) Chart:

Agios Pharmaceuticals, Inc (AGIO) News:

Below you will find a list of latest news for Agios Pharmaceuticals, Inc (AGIO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Agios Pharmaceuticals, Inc (AGIO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-03-20150CALL0 0232.04TRUE00
2026-03-2017.50CALL0 0205.33TRUE00
2026-03-20200CALL0 0168.72TRUE00
2026-03-2022.55.87CALL0 00TRUE00
2026-03-20252.85CALL0 662.41TRUE00
2026-03-20300.55CALL0 61259.99FALSE00
2026-03-20350.05CALL0 1090150.49FALSE00
2026-03-20400.24CALL0 1282.45FALSE00
2026-03-20150PUT0 0534.9FALSE00
2026-03-2017.50PUT0 0242.18FALSE00
2026-03-20200.4PUT0 1322.06FALSE00
2026-03-2022.50.19PUT0 30121.22FALSE00
2026-03-20250.19PUT0 99102.74FALSE00
2026-03-20304.3PUT0 2105.26TRUE00
2026-03-20358.1PUT0 170.12TRUE00
2026-03-20400PUT0 00TRUE00
2026-04-17150CALL0 0100.15TRUE00
2026-04-1717.50CALL0 00TRUE00
2026-04-17200CALL0 0108.41TRUE00
2026-04-1722.56.27CALL0 477.41TRUE00
2026-04-17255.93CALL0 136.18TRUE00
2026-04-17301.25CALL0 10754.92FALSE00
2026-04-17351.1CALL0 5101.16FALSE00
2026-04-17400CALL0 0116.01FALSE00
2026-04-17150PUT0 0253.27FALSE00
2026-04-1717.50PUT0 0102.22FALSE00
2026-04-17200PUT0 0131.02FALSE00
2026-04-1722.50.3PUT6 7162.24FALSE0.30
2026-04-17251.04PUT0 6063.61FALSE00
2026-04-17302.35PUT0 157TRUE00
2026-04-17350PUT0 064.64TRUE00
2026-04-17400PUT0 00TRUE00
2026-05-1512.513.2CALL0 1483.7TRUE00
2026-05-15150CALL0 055.9TRUE00
2026-05-1517.513CALL0 264.47TRUE00
2026-05-15209CALL0 1298.51TRUE00
2026-05-1522.57.95CALL0 1346.91TRUE00
2026-05-15254.5CALL0 37243.36TRUE00
2026-05-15302.39CALL0 67269.07FALSE00
2026-05-15351.15CALL0 45676.34FALSE00
2026-05-15400.64CALL10 87575.26FALSE0.640
2026-05-15450.3CALL0 8977.97FALSE00
2026-05-15500.15CALL0 44110.28FALSE00
2026-05-15550.77CALL0 15153.37FALSE00
2026-05-15601.15CALL0 22164.64FALSE00
2026-05-15650.46CALL0 7139.3FALSE00
2026-05-1512.50.75PUT0 1113.99FALSE00
2026-05-15150.15PUT0 15194.75FALSE00
2026-05-1517.52PUT0 1159.39FALSE00
2026-05-15200.5PUT0 322101.23FALSE00
2026-05-1522.51.15PUT0 10481.87FALSE00
2026-05-15251.8PUT0 8857.01FALSE00
2026-05-15304.35PUT0 63370.05TRUE00
2026-05-15358.8PUT0 46867.16TRUE00
2026-05-154016.4PUT0 4763.87TRUE00
2026-05-154514.3PUT0 40TRUE00
2026-05-155017.3PUT0 084.46TRUE00
2026-05-155523PUT0 00TRUE00
2026-05-15600PUT0 00TRUE00
2026-05-15650PUT0 00TRUE00
2026-08-211515.5CALL0 182.69TRUE00
2026-08-2117.50CALL0 072.85TRUE00
2026-08-21209.51CALL0 374.89TRUE00
2026-08-2122.510.5CALL0 276.62TRUE00
2026-08-21258.2CALL0 3178.48TRUE00
2026-08-21304.5CALL0 273.25FALSE00
2026-08-21354.11CALL0 3472.25FALSE00
2026-08-21402.87CALL0 4766.95FALSE00
2026-08-21451.67CALL0 8974.32FALSE00
2026-08-21151.25PUT0 8105.38FALSE00
2026-08-2117.51.35PUT0 98113.18FALSE00
2026-08-21201.6PUT0 572.44FALSE00
2026-08-2122.52.4PUT0 271.25FALSE00
2026-08-21253.3PUT0 3468.1FALSE00
2026-08-21305.2PUT0 9171.57TRUE00
2026-08-213512.5PUT0 2670.37TRUE00
2026-08-21400PUT0 072.24TRUE00
2026-08-21450PUT0 072.04TRUE00
2026-12-1812.50CALL0 081.36TRUE00
2026-12-18150CALL0 084.18TRUE00
2026-12-1817.50CALL0 076.03TRUE00
2026-12-182014.2CALL0 476.14TRUE00
2026-12-1822.510.8CALL0 778.47TRUE00
2026-12-18259.6CALL0 6979.05TRUE00
2026-12-18307CALL0 3224881.06FALSE00
2026-12-18356.7CALL0 25880.01FALSE00
2026-12-18405CALL0 5980.81FALSE00
2026-12-18455.5CALL0 6883.82FALSE00
2026-12-18505CALL0 92382.8FALSE00
2026-12-18554.5CALL0 182.93FALSE00
2026-12-18604.2CALL0 386.41FALSE00
2026-12-18653.5CALL0 2885.89FALSE00
2026-12-1812.50PUT0 090.19FALSE00
2026-12-18150PUT0 086.41FALSE00
2026-12-1817.50PUT0 098.9FALSE00
2026-12-18204.5PUT0 4974.99FALSE00
2026-12-1822.55.5PUT0 780.79FALSE00
2026-12-18256.5PUT0 2377.63FALSE00
2026-12-18309.8PUT0 13475.99TRUE00
2026-12-183513.4PUT0 23176.98TRUE00
2026-12-184016.8PUT0 8078.99TRUE00
2026-12-184522PUT0 6081.48TRUE00
2026-12-18500PUT0 080.76TRUE00
2026-12-18550PUT0 081.68TRUE00
2026-12-18600PUT0 081.8TRUE00
2026-12-18650PUT0 081.05TRUE00
2027-01-1512.514.45CALL0 1579.81TRUE00
2027-01-151514.8CALL0 876.35TRUE00
2027-01-1517.50CALL0 081.36TRUE00
2027-01-152011.73CALL0 479.99TRUE00
2027-01-1522.510.5CALL0 478.81TRUE00
2027-01-152511.2CALL0 3580.15TRUE00
2027-01-15308.5CALL0 12076.99FALSE00
2027-01-15355.75CALL1 4476.52FALSE5.750
2027-01-15406.2CALL0 4177.81FALSE00
2027-01-15454.86CALL0 2380.71FALSE00
2027-01-15503.1CALL0 6678.74FALSE00
2027-01-15550CALL0 0103.11FALSE00
2027-01-15601.85CALL0 1108.73FALSE00
2027-01-15652.05CALL0 13113.73FALSE00
2027-01-1512.52.19PUT0 3122.86FALSE00
2027-01-15151.25PUT0 53103.42FALSE00
2027-01-1517.50PUT0 089.71FALSE00
2027-01-15203.79PUT0 685.92FALSE00
2027-01-1522.56PUT0 60676.1FALSE00
2027-01-15255.7PUT0 159976.06FALSE00
2027-01-15308PUT0 17972.87TRUE00
2027-01-153513.35PUT0 1773.4TRUE00
2027-01-15400PUT0 078.4TRUE00
2027-01-15450PUT0 077.84TRUE00
2027-01-15500PUT0 076.59TRUE00
2027-01-15550PUT0 078.74TRUE00
2027-01-15600PUT0 078.23TRUE00
2027-01-15650PUT0 075.74TRUE00
2028-01-2112.518.7CALL0 676.97TRUE00
2028-01-211516.35CALL0 1275.21TRUE00
2028-01-2117.50CALL0 070.64TRUE00
2028-01-21200CALL0 067.39TRUE00
2028-01-2122.50CALL0 068.14TRUE00
2028-01-212512.1CALL0 967.85TRUE00
2028-01-213011.76CALL0 1365.34FALSE00
2028-01-21358.13CALL0 664.49FALSE00
2028-01-21407.07CALL0 1465.35FALSE00
2028-01-21456.1CALL0 764.91FALSE00
2028-01-21503.1CALL0 066.75FALSE00
2028-01-21556.7CALL0 164.42FALSE00
2028-01-21600CALL0 064.76FALSE00
2028-01-21655.21CALL0 164.53FALSE00
2028-01-2112.50PUT0 0123.58FALSE00
2028-01-21150PUT0 0102.48FALSE00
2028-01-2117.50PUT0 069.44FALSE00
2028-01-21206PUT0 367.63FALSE00
2028-01-2122.55.73PUT0 1769.41FALSE00
2028-01-21258.5PUT0 165.96FALSE00
2028-01-21300PUT0 067TRUE00
2028-01-21350PUT0 065.6TRUE00
2028-01-21400PUT0 065.84TRUE00
2028-01-214523.7PUT0 864.51TRUE00
2028-01-215027PUT0 1567.18TRUE00
2028-01-21550PUT0 065.22TRUE00
2028-01-21600PUT0 066TRUE00
2028-01-21650PUT0 065.94TRUE00

Latest AGIO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST11$17.4
Jun 13, 2022 7:59 PM EST189$17.4
Jun 13, 2022 7:59 PM EST128$17.4
Jun 13, 2022 7:59 PM EST200$17.38
Jun 13, 2022 7:59 PM EST17$17.4

Agios Pharmaceuticals, Inc (AGIO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000021545719003331/0000215457-19-003331-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506619000835/0000315066-19-000835-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620000791/0000315066-20-000791-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620001684/0000315066-20-001684-index.htm
2019-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423719000203/0000834237-19-000203-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423720008047/0000834237-20-008047-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221919000091/0000902219-19-000091-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221920000008/0000902219-20-000008-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119002231/0000932471-19-002231-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119004832/0000932471-19-004832-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-11-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064173/0001104659-19-064173-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920017624/0001104659-20-017624-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920018297/0001104659-20-018297-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518314801/0001193125-18-314801-index.htm
2018-11-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518328948/0001193125-18-328948-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518341083/0001193125-18-341083-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518353307/0001193125-18-353307-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519003167/0001193125-19-003167-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519018824/0001193125-19-018824-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039198/0001193125-19-039198-index.htm
2019-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039513/0001193125-19-039513-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519051918/0001193125-19-051918-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519107805/0001193125-19-107805-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110870/0001193125-19-110870-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110887/0001193125-19-110887-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519133821/0001193125-19-133821-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519134882/0001193125-19-134882-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519148009/0001193125-19-148009-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519162771/0001193125-19-162771-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519164072/0001193125-19-164072-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519166109/0001193125-19-166109-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519209747/0001193125-19-209747-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519237824/0001193125-19-237824-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519258364/0001193125-19-258364-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519275491/0001193125-19-275491-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519279631/0001193125-19-279631-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519283514/0001193125-19-283514-index.htm
2019-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519285887/0001193125-19-285887-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519288482/0001193125-19-288482-index.htm
2019-11-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519288495/0001193125-19-288495-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519298670/0001193125-19-298670-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519309199/0001193125-19-309199-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520005857/0001193125-20-005857-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520006338/0001193125-20-006338-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520034263/0001193125-20-034263-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520037796/0001193125-20-037796-index.htm
2020-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520041964/0001193125-20-041964-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109284/0001193125-20-109284-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109288/0001193125-20-109288-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520127627/0001193125-20-127627-index.htm
2020-04-30POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128793/0001193125-20-128793-index.htm
2020-04-30S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128809/0001193125-20-128809-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155665/0001193125-20-155665-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155682/0001193125-20-155682-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520203351/0001193125-20-203351-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520240994/0001193125-20-240994-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520249634/0001193125-20-249634-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520286235/0001193125-20-286235-index.htm
2018-09-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2018-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057372/0001209191-18-057372-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118059146/0001209191-18-059146-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119007343/0001209191-19-007343-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013509/0001209191-19-013509-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013515/0001209191-19-013515-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013525/0001209191-19-013525-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013531/0001209191-19-013531-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013536/0001209191-19-013536-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119025785/0001209191-19-025785-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922218000018/0001439222-18-000018-index.htm
2019-02-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000004/0001439222-19-000004-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000009/0001439222-19-000009-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000011/0001439222-19-000011-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000017/0001439222-19-000017-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000021/0001439222-19-000021-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2019-12-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000027/0001439222-19-000027-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000028/0001439222-19-000028-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000002/0001439222-20-000002-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000003/0001439222-20-000003-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2020-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000014/0001439222-20-000014-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000017/0001439222-20-000017-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000026/0001439222-20-000026-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000039/0001439222-20-000039-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000055/0001439222-20-000055-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000059/0001439222-20-000059-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000063/0001439222-20-000063-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000069/0001439222-20-000069-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223019000005/0001562230-19-000005-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223020000005/0001562230-20-000005-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003422/9999999997-19-003422-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003444/9999999997-19-003444-index.htm
2019-07-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719006154/9999999997-19-006154-index.htm

Agios Pharmaceuticals, Inc (AGIO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals, Inc (AGIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1133%
Institutional Ownership: 9234%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-28Carman AlensonPrincipal Accounting OfficerSell152.0076.4511,620.400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2020-02-16David P SchenkeinDirectorBuy8,125.00105,692.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-22David P SchenkeinDirectorBuy2,775.00105,933.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-04-13Christopher BowdenChief Medical OfficerBuy5,280.0010,598.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerSell5,000.0066.01330,050.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerSell5,000.0068.00340,000.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell5,854.0066.03386,539.6211,384.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-05-20Christopher BowdenChief Medical OfficerBuy3,583.0035.16125,978.2811,889.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2019-02-16Steven L. HoerterChief Commercial OfficerBuy2,750.0011,981.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-16Andrew HirschChief Financial OfficerBuy2,750.0013,195.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-05-31IAN T CLARKDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-31JACQUALYN A FOUSEChief Executive OfficerBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-31Maykin HoDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-31Paul J ClancyDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-01-20Andrew HirschChief Financial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-01-20Steven L. HoerterChief Commercial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2020-02-16Andrew HirschChief Financial OfficerBuy2,750.0015,127.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-04Christopher BowdenChief Medical OfficerBuy8,526.0035.16299,774.1615,841.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell14,191.0050.03709,962.961,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell35,447.0050.101,776,025.851,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-11Christopher BowdenChief Medical OfficerSell621.0050.0231,063.231,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-13Christopher BowdenChief Medical OfficerSell7,100.0050.16356,111.861,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-03-15Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-02-22Andrew HirschChief Financial OfficerBuy3,333.0017,574.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2019-11-12CORP /DE/ CELGENE10% Share HolderBuy403,225.0031.0012,499,975.001,777,824.00https://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-12-26Carman AlensonPrincipal Accounting OfficerSell2,950.0050.09147,765.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-02-20Carman AlensonPrincipal Accounting OfficerSell2,427.0053.37129,528.99184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-26Carman AlensonPrincipal Accounting OfficerSell472.0047.1222,240.64184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-03-02Carman AlensonPrincipal Accounting OfficerSell345.0047.3016,318.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-09-02Carman AlensonPrincipal Accounting OfficerSell250.0039.939,982.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2019-05-31David ScaddenDirectorBuy1,400.001,971.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2020-04-13Andrew HirschChief Financial OfficerBuy5,387.0021,905.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2018-09-12JOHN MARAGANOREDirectorSell14,162.0071.741,015,981.8822,047.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-11Christopher BowdenChief Medical OfficerBuy621.0035.1621,834.362,271.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2018-12-21Scott BillerChief Scientific OfficerBuy20,500.002.3447,918.7524,637.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2020-04-22Andrew HirschChief Financial OfficerBuy5,893.0026,199.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2019-02-27Scott BillerChief Scientific OfficerSell9,000.0065.00585,000.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0068.2213,644.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell599.0068.1240,803.8826,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell2,600.0067.73176,098.0026,711.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy428.0031.6413,541.9226,939.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell2,401.0067.61162,331.6127,110.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-02-16Scott BillerChief Scientific OfficerBuy2,750.0027,387.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy1,766.000.47830.0228,277.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0066.4513,290.0029,311.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy2,572.0039.76102,262.7229,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerBuy3,000.0039.76119,280.0029,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2020-05-29JOHN MARAGANOREDirectorBuy1,878.0030,172.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy4,154.009.0537,593.7032,431.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2020-05-29IAN T CLARKDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-05-29Maykin HoDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-05-29Paul J ClancyDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2019-06-11Scott BillerChief Scientific OfficerBuy7,218.002.3416,872.0833,729.00https://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy3,080.0031.6497,451.2035,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-05-31Kaye I Foster-CheekDirectorBuy1,400.003,600.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2018-09-11JOHN MARAGANOREDirectorSell2,400.0073.82177,168.0036,209.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-05Christopher BowdenChief Medical OfficerBuy35,447.0035.161,246,316.5237,097.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-05-31JOHN MARAGANOREDirectorBuy1,400.0037,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy2,800.003,774.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-02-21Carman AlensonPrincipal Accounting OfficerBuy3,300.003,812.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2020-05-29David ScaddenDirectorBuy1,878.003,849.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2018-09-11JOHN MARAGANOREDirectorSell11,155.0072.52808,960.6038,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2019-11-13JACQUALYN A FOUSEChief Executive OfficerBuy40,322.0031.001,249,982.0041,722.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2020-02-16Christopher BowdenChief Medical OfficerBuy2,750.004,400.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell21.0071.771,507.1750,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell100.0071.427,142.0050,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell1,100.0071.0578,155.0050,953.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell700.0070.2349,161.0051,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell2,200.0069.44152,768.0051,732.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell979.0069.4768,011.1352,053.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell900.0068.5661,704.0053,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2020-04-13JACQUALYN A FOUSEChief Executive OfficerBuy12,379.0054,101.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-05-29Kaye I Foster-CheekDirectorBuy1,878.005,478.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-04-13Bruce CarChief Scientific OfficerBuy6,874.006,874.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-02-22Christopher BowdenChief Medical OfficerBuy3,333.006,914.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2019-01-20Christopher BowdenChief Medical OfficerBuy6,265.007,189.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell1,300.0064.6484,032.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell100.0068.726,872.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy72,619.002.34169,928.4672,619.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell1,500.0068.09102,135.007,338.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy2,500.0031.6479,100.0075,119.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00790.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-16Christopher BowdenChief Medical OfficerBuy2,750.008,013.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2020-05-20Christopher BowdenChief Medical OfficerSell3,583.0050.01179,200.168,306.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2018-09-10David P SchenkeinChief Executive OfficerBuy8,730.0031.64276,217.2083,849.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2020-04-13Jonathan BillerChief Legal OfficerBuy8,523.008,523.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell8,700.0064.09557,583.008,538.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2020-02-22Carman AlensonPrincipal Accounting OfficerBuy691.00875.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-13Christopher BowdenChief Medical OfficerBuy7,100.0035.16249,636.008,750.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell2,546.0066.85170,200.108,838.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-02-16David P SchenkeinDirectorBuy8,125.0091,974.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00974.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-11-13David P SchenkeinDirectorBuy8,064.0031.00249,984.0097,567.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm